To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Latest action · Mar 17, 2023 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 7, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)
Cosponsors 18
Members who signed on, in the order they did. Signatures ran from Mar 7, 2023 to Jul 2, 2024; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-SC | Nancy Mace | Original | Mar 7, 2023 |
| R-OH | Bill Johnson | May 25, 2023 | |
| D-OR | Earl Blumenauer | May 25, 2023 | |
| D-TX | Jasmine Crockett | Jun 23, 2023 | |
| R-TX | Morgan Luttrell | Jun 23, 2023 | |
| R-NY | Brandon Williams | Jul 19, 2023 | |
| R-IA | Mariannette Miller-Meeks | Jul 19, 2023 | |
| D-CA | Ro Khanna | Jul 19, 2023 | |
| D-CA | Robert Garcia | Jul 19, 2023 | |
| D-TX | Colin Z. Allred | Mar 8, 2024 | |
| R-WI | Derrick Van Orden | Mar 8, 2024 | |
| R-NE | Don Bacon | Mar 8, 2024 | |
| D-CA | Mike Thompson | Mar 8, 2024 | |
| D-CA | Ted Lieu | Mar 8, 2024 | |
| D-NJ | Bonnie Watson Coleman | Jul 2, 2024 | |
| R-IN | James R. Baird | Jul 2, 2024 | |
| D-TX | Sheila Jackson Lee | Jul 2, 2024 | |
| R-IA | Zachary Nunn | Jul 2, 2024 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 7, 2023 |
| Health Subcommittee | Referred Mar 17, 2023 | |
| House | Judiciary Committee | Referred Mar 7, 2023 |
Actions 3
Everything that happened, newest first.
- Mar 17, 2023Referred to the Subcommittee on Health.
- Mar 7, 2023Introduced in House
- Mar 7, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 43, March 7, 2023, page H1151.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 689 | A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes. | Related bill | Mar 7, 2023 |
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 1
Each version as it was printed, newest first.
- Mar 7, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
